Trials / Unknown
UnknownNCT02957279
Dendritic Cells-Derived Exosomes in Human Sepsis
A Cohort Study to Investigate the Impacts of Peripheral Blood Dendritic Cells-Derived Exosomes at Early Phase on the Prognosis in Human Sepsis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The amount of peripheral blood exosomes has been confirmed to change in the endotoxin-induced infection. The primary objectives of this study are to compare the changes of peripheral blood dendritic cell-derived exosomes in the patients with sepsis and the healthy controls.
Detailed description
This is a prospective, single-centered, clinical cohort study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antibiotics | In the sepsis group, antibiotics were used when needed. |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-09-01
- Completion
- 2017-10-01
- First posted
- 2016-11-07
- Last updated
- 2016-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02957279. Inclusion in this directory is not an endorsement.